234
Participants
Start Date
January 20, 2018
Primary Completion Date
November 30, 2025
Study Completion Date
February 1, 2026
Cetuximab + FOLFIRI
Cetuximab 400 mg/m2 will be administered in the first dose and 250 mg/m2 will be administered in the next doses every week. Irinotecan will be administered 180 mg/m2 biweekly. Leucovorin will be administered 400 mg/m2 biweekly.Fluorouracil will be administered 400 mg/m2 push, and 2400 mg/m2 as 46-h infusion biweekly.
RECRUITING
Taleqani Hospital, Tehran
Lead Sponsor
Cinnagen
INDUSTRY